Literature DB >> 25673747

Altered excitatory and inhibitory inputs to striatal medium-sized spiny neurons and cortical pyramidal neurons in the Q175 mouse model of Huntington's disease.

Tim Indersmitten1, Conny H Tran1, Carlos Cepeda1, Michael S Levine2.   

Abstract

The Q175 knockin mouse model of Huntington's disease (HD) carries a CAG trinucleotide expansion of the human mutant huntingtin allele in its native mouse genomic context and recapitulates the genotype more closely than transgenic models. In this study we examined the progression of changes in intrinsic membrane properties and excitatory and inhibitory synaptic transmission, using whole cell patch-clamp recordings of medium-sized spiny neurons (MSNs) in the dorsolateral striatum and cortical pyramidal neurons (CPNs) in layers 2/3 of the primary motor cortex in brain slices from heterozygous (Q175(+/-)) and homozygous (Q175(+/+)) mice. Input resistance in MSNs from Q175(+/+) and Q175(+/-) mice was significantly increased compared with wild-type (WT) littermates beginning at 2 mo. Furthermore, the frequency of spontaneous and miniature excitatory postsynaptic currents (EPSCs) was significantly reduced in MSNs from Q175(+/+) and Q175(+/-) mice compared with WTs beginning at 7 mo. In contrast, the frequency of spontaneous inhibitory postsynaptic currents (sIPSCs) and IPSC-to-EPSC ratios were increased in MSNs from Q175(+/+) mice beginning at 2 mo. Morphologically, significant decreases in spine density of MSNs from Q175(+/-) and Q175(+/+) mice occurred at 7 and 12 mo. In CPNs, sIPSC frequencies and IPSC-to-EPSC ratios were significantly increased in Q175(+/-) mice compared with WTs at 12 mo. There were no changes in intrinsic membrane properties or morphology. In summary, we show a number of alterations in electrophysiological and morphological properties of MSNs in Q175 mice that are similar to other HD mouse models. However, unlike other models, CPN inhibitory activity is increased in Q175(+/-) mice, indicating reduced cortical excitability.
Copyright © 2015 the American Physiological Society.

Entities:  

Keywords:  Huntington's disease; Q175; cerebral cortex; electrophysiology; striatum

Mesh:

Year:  2015        PMID: 25673747      PMCID: PMC4416625          DOI: 10.1152/jn.01056.2014

Source DB:  PubMed          Journal:  J Neurophysiol        ISSN: 0022-3077            Impact factor:   2.714


  47 in total

1.  Electrophysiological and morphological changes in striatal spiny neurons in R6/2 Huntington's disease transgenic mice.

Authors:  G J Klapstein; R S Fisher; H Zanjani; C Cepeda; E S Jokel; M F Chesselet; M S Levine
Journal:  J Neurophysiol       Date:  2001-12       Impact factor: 2.714

2.  Extensive early motor and non-motor behavioral deficits are followed by striatal neuronal loss in knock-in Huntington's disease mice.

Authors:  M A Hickey; A Kosmalska; J Enayati; R Cohen; S Zeitlin; M S Levine; M-F Chesselet
Journal:  Neuroscience       Date:  2008-08-27       Impact factor: 3.590

3.  Abnormal cortical synaptic plasticity in a mouse model of Huntington's disease.

Authors:  Damian M Cummings; Austen J Milnerwood; Glenn M Dallérac; Sarat C Vatsavayai; Mark C Hirst; Kerry P S J Murphy
Journal:  Brain Res Bull       Date:  2006-11-16       Impact factor: 4.077

Review 4.  Knock-in mouse models of Huntington's disease.

Authors:  Liliana B Menalled
Journal:  NeuroRx       Date:  2005-07

5.  Longitudinal evaluation of the Hdh(CAG)150 knock-in murine model of Huntington's disease.

Authors:  Mary Y Heng; Sara J Tallaksen-Greene; Peter J Detloff; Roger L Albin
Journal:  J Neurosci       Date:  2007-08-22       Impact factor: 6.167

6.  Early motor dysfunction and striosomal distribution of huntingtin microaggregates in Huntington's disease knock-in mice.

Authors:  Liliana B Menalled; Jessica D Sison; Ying Wu; Melisa Olivieri; Xiao-Jiang Li; He Li; Scott Zeitlin; Marie-Françoise Chesselet
Journal:  J Neurosci       Date:  2002-09-15       Impact factor: 6.167

7.  Multiple sources of striatal inhibition are differentially affected in Huntington's disease mouse models.

Authors:  Carlos Cepeda; Laurie Galvan; Sandra M Holley; Shilpa P Rao; Véronique M André; Elian P Botelho; Jane Y Chen; Joseph B Watson; Karl Deisseroth; Michael S Levine
Journal:  J Neurosci       Date:  2013-04-24       Impact factor: 6.167

8.  Time course of early motor and neuropathological anomalies in a knock-in mouse model of Huntington's disease with 140 CAG repeats.

Authors:  Liliana B Menalled; Jessica D Sison; Ioannis Dragatsis; Scott Zeitlin; Marie-Françoise Chesselet
Journal:  J Comp Neurol       Date:  2003-10-06       Impact factor: 3.215

9.  Mutant huntingtin causes context-dependent neurodegeneration in mice with Huntington's disease.

Authors:  Zhao-Xue Yu; Shi-Hua Li; Joy Evans; Ajay Pillarisetti; He Li; Xiao-Jiang Li
Journal:  J Neurosci       Date:  2003-03-15       Impact factor: 6.167

10.  Pathological cell-cell interactions are necessary for striatal pathogenesis in a conditional mouse model of Huntington's disease.

Authors:  Xiaofeng Gu; Véronique M André; Carlos Cepeda; Shi-Hua Li; Xiao-Jiang Li; Michael S Levine; X William Yang
Journal:  Mol Neurodegener       Date:  2007-04-30       Impact factor: 14.195

View more
  30 in total

Review 1.  Unravelling and Exploiting Astrocyte Dysfunction in Huntington's Disease.

Authors:  Baljit S Khakh; Vahri Beaumont; Roger Cachope; Ignacio Munoz-Sanjuan; Steven A Goldman; Rosemarie Grantyn
Journal:  Trends Neurosci       Date:  2017-05-31       Impact factor: 13.837

2.  Striatal GABAergic interneuron dysfunction in the Q175 mouse model of Huntington's disease.

Authors:  Sandra M Holley; Laurie Galvan; Talia Kamdjou; Carlos Cepeda; Michael S Levine
Journal:  Eur J Neurosci       Date:  2018-12-10       Impact factor: 3.386

3.  Differential electrophysiological and morphological alterations of thalamostriatal and corticostriatal projections in the R6/2 mouse model of Huntington's disease.

Authors:  Anna Parievsky; Cindy Moore; Talia Kamdjou; Carlos Cepeda; Charles K Meshul; Michael S Levine
Journal:  Neurobiol Dis       Date:  2017-07-27       Impact factor: 5.996

4.  Complete but not partial inhibition of glutamate transporters exacerbates cortical excitability in the R6/2 mouse model of Huntington's disease.

Authors:  Ana María Estrada-Sánchez; Daniel Castro; Kenia Portillo-Ortiz; Katrina Jang; Michael Nedjat-Haiem; Michael S Levine; Carlos Cepeda
Journal:  CNS Neurosci Ther       Date:  2018-10-11       Impact factor: 5.243

5.  SorCS2-mediated NR2A trafficking regulates motor deficits in Huntington's disease.

Authors:  Qian Ma; Jianmin Yang; Teresa A Milner; Jean-Paul G Vonsattel; Mary Ellen Palko; Lino Tessarollo; Barbara L Hempstead
Journal:  JCI Insight       Date:  2017-05-04

6.  Influence of cortical synaptic input on striatal neuronal dendritic arborization and sensitivity to excitotoxicity in corticostriatal coculture.

Authors:  Caodu Buren; Gaqi Tu; Matthew P Parsons; Marja D Sepers; Lynn A Raymond
Journal:  J Neurophysiol       Date:  2016-04-27       Impact factor: 2.714

Review 7.  Disrupted striatal neuron inputs and outputs in Huntington's disease.

Authors:  Anton Reiner; Yun-Ping Deng
Journal:  CNS Neurosci Ther       Date:  2018-04       Impact factor: 5.243

8.  Striatal network modeling in Huntington's Disease.

Authors:  Adam Ponzi; Scott J Barton; Kendra D Bunner; Claudia Rangel-Barajas; Emily S Zhang; Benjamin R Miller; George V Rebec; James Kozloski
Journal:  PLoS Comput Biol       Date:  2020-04-17       Impact factor: 4.475

9.  An enhanced Q175 knock-in mouse model of Huntington disease with higher mutant huntingtin levels and accelerated disease phenotypes.

Authors:  Amber L Southwell; Amy Smith-Dijak; Chris Kay; Marja Sepers; Erika B Villanueva; Matthew P Parsons; Yuanyun Xie; Lisa Anderson; Boguslaw Felczak; Sabine Waltl; Seunghyun Ko; Daphne Cheung; Louisa Dal Cengio; Ramy Slama; Eugenia Petoukhov; Lynn A Raymond; Michael R Hayden
Journal:  Hum Mol Genet       Date:  2016-07-04       Impact factor: 6.150

10.  Striosomes Mediate Value-Based Learning Vulnerable in Age and a Huntington's Disease Model.

Authors:  Alexander Friedman; Emily Hueske; Sabrina M Drammis; Sebastian E Toro Arana; Erik D Nelson; Cody W Carter; Sebastien Delcasso; Raimundo X Rodriguez; Hope Lutwak; Kaden S DiMarco; Qingyang Zhang; Lara I Rakocevic; Dan Hu; Joshua K Xiong; Jiajia Zhao; Leif G Gibb; Tomoko Yoshida; Cody A Siciliano; Thomas J Diefenbach; Charu Ramakrishnan; Karl Deisseroth; Ann M Graybiel
Journal:  Cell       Date:  2020-10-27       Impact factor: 41.582

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.